SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending as traders discuss potential catalysts including AI integration, a possible buyout, and speculation around increased interest from Reddit's WallStreetBets community. Community members are actively debating price targets, potential acquirers, and the impact of AI on the platform's future, while also noting the stock's high short interest and recent trading volume.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending as the FDA considers the ineffectiveness of phenylephrine, an ingredient in popular decongestants like Sudafed PE, potentially impacting sales. Despite this, some analysts remain bullish, citing attractive entry points and a recent addition to the S&P 500, with the community actively monitoring price movements for potential buying opportunities.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending amid discussions around its correlation to crypto markets and AI data center prospects, with some traders expressing frustration over its price action and potential manipulation. Community members are debating its valuation and future performance, particularly in relation to upcoming earnings and Helios updates. Bearish sentiment is emerging with some traders targeting lower price points.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses its potential, highlighting its speed and efficiency compared to other blockchains like Ethereum. Discussions also involve meme coins built on Solana, with some users anticipating a strong rally. Additionally, the recent Alpenglow upgrade, aimed at boosting transaction speeds, has generated buzz.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

MSFT is trending due to discussions around potential AI competition and overall market performance following key earnings reports. Community members are weighing the stock's value compared to other tech giants, with some eyeing potential options plays and reversals, while others express concern over its recent underperformance and downward momentum. The conversation includes speculation about factors influencing the stock's price, ranging from CEO share sales to broader economic indicators.

Krypto Cock is a meme-powered crypto project with real onchain utility. Born from the lessons of past market cycles, $COCK blends humor, culture, and technology to create a unique community-driven ecosystem.  The project is focused on: • Building lightweight mini-apps for Farcaster and other onchain platforms • Developing an engaged, growing community • Delivering consistent, high-quality content • Offering practical onchain tools and experiences • Led by a team with years of crypto and product experience  $COCK aims to make the crypto experience more fun, accessible, and connected, without sacrificing purpose or quality.

CockCardano

$COCK.X is trending as the community rallies around the upcoming launch of Cocky Wings LLC, a real-world food business associated with the Cardano-based meme coin. Community members highlight the potential for passive income through staking and are excited about the partnership with $SNEK.X and the presence at the South Carolina Gamecocks home game.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending amid speculation about potential S&P 500 inclusion and excitement surrounding the launch of NFL and college football prediction markets on the platform. Community discussions revolve around whether the stock will be added to the S&P 500, with some anticipating a surge if it happens, while others focus on the potential revenue boost from the new sports betting feature. The stock's behavior relative to the broader market and key technical levels are also being closely monitored.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a recent analyst downgrade impacting investor sentiment, while some community members view the dip as a buying opportunity. Community talking points include the sustainability of AMD's growth, competition with NVIDIA and Broadcom, and potential price targets. Despite the selloff, some express confidence in AMD's long-term prospects, particularly in the AI and data center markets.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about the Epstein files and Trump's potential involvement, with some users calling for their release while others defend him. Community members are also debating the stock's valuation and the broader implications of Trump's policies on the economy and international relations. The stock is highly divisive, with many users expressing strong opinions for and against Trump and his company.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI (SOUN) is trending as chatter increases around a potential short squeeze, driven by high short interest and bullish technical indicators. The community is also discussing recent partnerships in the healthcare sector and potential expansion into new verticals, with some speculating about a possible buyout. Bullish sentiment is building as traders focus on key price levels and the company's long-term potential in the AI voice space.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Vertex (VRTX) Up 6.9% Since Last Earnings Report?

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

CRISPR Therapeutics pushes beyond Casgevy with in vivo programs like CTX310, CTX320 and plans for two more studies by 2025-end.

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock

CRSP surges 41.4% in three months, fueled by promising CTX310 study data and accelerating Casgevy sales.

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?

CRSP's Casgevy records a 114% sales jump sequentially in Q2, fueling optimism for sustained revenues and long-term growth.

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets.

VRTX Q2 Earnings Beat, Stock Down as Pain Drug Misses Study Goal

Vertex beats second-quarter earnings and revenue estimates, but shares slide as pain drug VX-993 misses study goal.

Shares of Vertex Pharmaceuticals (VRTX) slumped 12% in the pre-market session on Tuesday after several brokerages lowered their price target on the stock after the company shared disappointing news about its drug pipeline.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VRTX">VRTX</a> jumped from ‘neutral’ to ‘extremely bullish’ over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels. According to Stocktwits data, retail chatter around the stock jumped 5300% in the past 24 hours.<figure class="image"><img style="aspect-ratio:632/59;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_05_at_8_26_17_AM_png_451b654aa4.webp" alt="VRTX's Sentiment Meter and Message Volume as of 8:25 a.m. ET on Aug. 5, 2025 | Source: Stocktwits" width="632" height="59"><figcaption>VRTX's Sentiment Meter and Message Volume as of 8:25 a.m. ET on Aug. 5, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user termed the stock slump an overreaction and noted that it is, instead, a buying opportunity.<stembedurl>https://stocktwits.com/lhes/message/623731239</stembedurl>Another highlighted the company’s upbeat Q2 earnings.<stembedurl>https://stocktwits.com/MissionImpossibl/message/623740227</stembedurl>Vertex on Monday said that treatment with its investigational pain drug <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.vrtx.com/news-releases/news-release-details/vertex-announces-results-phase-2-study-vx-993-treatment-acute">VX-993</a> did not result in statistically significant improvement in acute pain after bunionectomy surgery in a mid-stage study. Based on the results, the company said that it will not progress the drug as a solo treatment for acute pain anymore.The company also said that it would not advance its FDA-approved pain medication Journavx into a late-stage trial for studying its impact in lumbosacral radiculopathy (LSR), a condition where nerve roots in the lower back are compressed or irritated, causing pain and other neurological symptoms.Instead, the company said it would prioritize testing of Journavx in treating diabetic peripheral neuropathy or pain caused by nerve damage caused by diabetes. The decision was made following discussion with the FDA, it said.&nbsp;The updates spurred multiple price target cuts:<ul style="list-style-type:square;"><li>Morgan Stanley lowered its price target on Vertex to $439 from $460 and kept an ‘Equal Weight’ rating on the shares.&nbsp; Pipeline setbacks, including Journavx not advancing into a late-stage trial in lumbosacral radiculopathy (LSR) and pain signal inhibitor VX-993 being found to be not differentiated in acute pain, likely will be a focus and drive weakness in the stock despite Vertex having posted a Q2 beat, the analyst told investors.</li><li>H.C. Wainwright lowered the firm's price target on Vertex Pharmaceuticals to $478 from $550 to reflect the company’s updates on its pipeline. The firm, however, kept a ‘Buy’ rating on the shares.&nbsp;</li><li>BMO Capital, meanwhile, lowered the firm's price target on Vertex Pharmaceuticals to $530 from $557 and kept an ‘Outperform’ rating on the shares. The company's "impressive" commercial quarter was largely offset by the portfolio updates, the analyst told investors in a research note.</li></ul>For the second quarter, Vertex reported total revenue of $2.96 billion, a 12% increase compared to Q2 2024, and above an analyst estimate of $2.91 billion, according to data from Fiscal AI.Adjusted and diluted earnings per share came in at $4.52, above an expected $4.25.VRTX stock is up by 17% this year but down by about 1% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-germany-sales-slump-55-percent-in-july/chrLY84Rd2I">Tesla Germany Sales Slump 55% In July: Retail Believes Stock Is Not Affected By Bad News Anymore</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, Vertex Pharmaceuticals' logo is displayed on a smartphone screen in front of a stock chart. (Photo illustration by Cheng Xin/Getty Images)

Vertex Stock Sinks 12% As Pipeline Setbacks Trigger Wall Street Skepticism: But Retail Sees Opportunity 

Pipeline setbacks likely will be a focus and drive weakness in the stock despite Vertex having posted a Q2 beat, Morgan Stanley told investors.

Equity

Pipeline setbacks likely will be a focus and drive weakness in the stock despite Vertex having posted a Q2 beat, Morgan Stanley told investors.


Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

$APP

$MSTR

$HOOD

other (drop a comment)

The S&amp;P 500 rebalance announcement is today — which stock do you think has the best shot at getting added?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$4.61	--	--	N/A
Q2 '25	$4.27	$4.52	5.80%	BEAT
Q1 '25	$4.25	$4.06	-4.37%	MISSED
Q4 '24	$4.02	$3.98	-0.90%	MISSED
Q3 '24	$4.08	$4.38	7.41%	BEAT

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest VRTX News

VRTX Vertex Pharmaceuticals, Inc.